Nicholas Aberle, MD
Orthopaedic Surgery · Kansas City, KSNPI 1659578060
Payments from drug & device makers
Across 30 payments — averaging $46.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Titan Surgical Group, LLC$617
- Smith+Nephew$154
- Stryker$115
- Medacta USA, Inc.$80
- Kowa Pharmaceuticals America, Inc.$61
- Pacira Pharmaceuticals Incorporated$41
- plus $315 from 14 others
What the payments were for
- Food & beverage$76655%
- Education$61745%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Titan Surgical Group, LLC | 1 | $617 |
| Smith+Nephew | 3 | $154 |
| Stryker | 4 | $115 |
| Medacta USA, Inc. | 1 | $80 |
| Kowa Pharmaceuticals America, Inc. | 4 | $61 |
| Pacira Pharmaceuticals Incorporated | 2 | $41 |
| Bioventus LLC | 2 | $39 |
| Integra Lifesciences Corporation | 1 | $35 |
| Encore Medical, LP | 1 | $34 |
| Organogenesis Inc. | 1 | $31 |
| Polynovo North America LLC | 1 | $24 |
| Zimmer Biomet | 1 | $22 |
| Optinose US, Inc. | 1 | $22 |
| Heron Therapeutics, Inc. | 1 | $19 |
| Kaleo, Inc. | 1 | $16 |
| Merck | 1 | $16 |
| GSK | 1 | $15 |
| Melinta Therapeutics, LLC | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| AbbVie | 1 | $12 |
How this compares
$1,383 in reported general payments places this provider in the 35th percentile of 197 orthopaedic surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 13 | $810 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 53 | $759 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $447 |
| Oxycodone Hcl | 15 | $128 |
| Tramadol Hcl | 21 | $114 |
| Celecoxib | 11 | $89 |
| Meloxicam | 36 | $73 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Kansas City
- David AndersonKansas City$490K
- Brandon CarlsonKansas City$299K
- Brent WiseKansas City$97K
- Bryan VopatKansas City$56K
- John SchroeppelKansas City$40K
- Mitchell BirtKansas City$26K
- Spencer FalconKansas City$23K
- Katie SmeltzerKansas City$19K
- Everett WilkinsonKansas City$12K
- Jacob BrubacherKansas City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.